Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NPC-08 implant in malignant glioma and glioblastoma
NCT00919737Phase 2Completed
- Sponsor
- Nobelpharma Co., Ltd.
- Start
- Jun 2009
- Primary completion
- Apr 2011
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carmustine in malignant glioma, glioblastoma multiforme (GBM), sponsored by Nobelpharma Co., Ltd.. Started Jun 2009; status: completed.
02
Drugs
carmustine
03
Conditions
malignant gliomaglioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00919737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00919737.